Cancer Prognosis


MPI develops prognostic assays for cancer. The microRNA-based LungChip Prognosticator has completed Phase III clinical testing and is headed for regulatory approval and marketing in 2014.


DNA Microarray Service


For your gene / drug discovery needs MPI offers highest quality, bioinformatics expertise, turn-around time and cost-effectiveness for your research projects (SNP, mRNA, microRNA).

Companion Diagnostics


MPI develops Companion Diagnostics for cancer drugs from biotech and pharma.

With more than 78 Companion Diagnostics developed, the speed, universality, accuracy, success rate and clinical validation of our technology is unrivaled in the field.

Venlighedsvej 1  DK-2970 Hoersholm Denmark  CVR: 28106351 IR@medical-prognosis.com